Type 2 Diabetes in the Latino Population in the U.S.: a growing challenge
Revisión -
Vol.24 N.4 julio-agosto 2008A.E. Caballero11. Director of the Latino Diabetes Initiative. Director, Medical Affairs, Professional Education. Joslin Diabetes Center. Harvard Medical School. Boston (USA)
Resumen
The Latino or Hispanic group in the United States of America has
become the largest minority in the country, representing 13.7% of
the total population. It is estimated that by the year 2050, 1 in 4
individuals will belong to this group. This population suffers from very
high rates of type 2 diabetes, obesity, the metabolic syndrome, and
their multiple vascular complications. Generally speaking, there is a
genetic tendency to develop insulin resistance, abdominal obesity
and beta cell dysfunction that in combination with multiple nutritional,
life-style, socio-economic and cultural factors influence the development
and course of type 2 diabetes in this high-risk group. Unfortunately,
Latinos have lagged behind in their health care in the U.S.
when compared to the mainstream white population. There are multiple
and complex patient, health care provider and health care system
factors that contribute to this health care disparity. Therefore, it
is imperative to understand all the factors that contribute to the high
rates of type 2 diabetes and suboptimal diabetes care in this group
to develop and implement effective strategies to help this population.
The gained experience through the work with this population may be
helpful for the development of diabetes care programs in other parts
of the world that aim at improving the care of underserved and disadvantaged
populations.
Correspondencia
Correspondencia: A.E. Caballero, MD. Director of the Latino Diabetes Initiative. Director, Medical
Affairs, Professional Education. Joslin Diabetes Center. Harvard Medical School.
Boston, MA. E-mail:
enrique.caballero@joslin.harvard.eduPalabras clave
culture diabetes mellitus disparities Hispanic Latino Documento
Documento PDF»
‹ Volver